Caidya's review of ASCO 2024

Catch the Moments from ASCO 2024! If you missed being at ASCO 2024, don’t worry! I've got a recap for you. We've compiled a video showcasing the powerful connections and insightful discussions from the event. 👉 Click below to watch! #ASCO2024 #HealthcareInnovation #OncologyResearch #Caidya

📣 Dive Deeper into STING & TLR Innovations! 🚀 Missed our recent webinar, "Harnessing STING & TLR: Current Developments, Clinical Trials, and Key Players in the Landscape"? Don't worry, you can still catch up! Watch the session on demand to explore the latest advancements in the STING & TLR pipeline, discover new combination therapies, and dive into innovative strategies shaping the future of treatment. 🔗 Watch Now: https://ter.li/z3x8at Stay informed and ahead in the dynamic field of STING & TLR-targeted therapies! #ImmunoOncology #STING #TLR #Checkpoint

In 2024, remarkable achievements and exciting developments marked the year's progress. At Ocugen's NASDAQ event, meeting patients (with three different diseases (RP, AMD, Stargardt's) benefiting from therapies I developed was a profound experience (photo). Their improved and stable vision post-treatment stands as one of the most significant milestones. The ongoing trials for RP and AMD have displayed promising outcomes, with Phase III for RP and Phase I/II for AMD progressing positively. I have tremendous gratitude for everyone who contributed to this journey towards realizing my vision for powerful and broad therapies to treat multiple ocular diseases. Ocugen @NIH-NEI BrightFocus Foundation @amdf Matthew Levine Jennifer Williams Shannon McNamee Monica Akula Zoe Love Juliana de Oliveira santos Meg DeAngelis Wallace Thoreson Cheryl Mae Craft, Ph.D. and many others. Shifa Precision's entry into the C10 Labs accelerator program signifies a pivotal moment. Establishing crucial connections and presenting an innovative demo at the hackathon set the stage for future successes. Shahid Azim Beth Porter David Berlin Looking forward to 2025, the focus remains on driving impactful changes in human health. The mission is clear: revolutionize healthcare through precision medicine, predictive strategies, and proactive care. Physicians and healthcare leaders keen on enhancing healthcare accessibility and quality are welcome to join us in shaping a healthier future for all. Let's unite our efforts in 2025 to further elevate healthcare innovation and pave the way for a healthier world! #HealthcareInnovation #PrecisionMedicine #FutureOfHealthcare #therapies

Sean Bartholomew and Stephen Ondek of #TeamGermfree sat down with IBTV at Advanced Therapies Week to discuss the Clinical Readiness Symposium Germfree hosted onsite. 👀 The symposium brought together experts across the cell and gene therapy space to explore how a ‘total solution’ approach can improve patient access at the clinical site. They also shared key insights on emerging trends that are set to shape 2025. 💪 Check out the interview below. ⬇️ More insights from the symposium coming soon! #ATW25 #CellTherapy #GeneTherapy #Innovation #ClinicalReadiness #DecentralizedManufacturing

Save these dates for free, upcoming webinars hosted by @AHNSEndo and @ThyCaInc Topics will be announced as the dates approach, along with registration details. #ThyroidCancer #ThyCa #ThyroidCancerSurvivor #ThyCaSurvivor #ThyroidCancerWarrior #ThyCaWarrior #KnowledgeIsPower

Save these dates for free, upcoming webinars hosted by @AHNSEndo and @ThyCaInc Topics will be announced as the dates approach, along with registration details. #ThyroidCancer #ThyCa #ThyroidCancerSurvivor #ThyCaSurvivor #ThyroidCancerWarrior #ThyCaWarrior #KnowledgeIsPower

📣 Get updated recommendations in the ESMO #GastricCancer Living Guideline v1.3 prepared by Florian Lordick and Elizabeth (Lizzy) Smyth 👉 an essential update for your daily practice. 🔗 https://ow.ly/GtWt50StqPk

Can't wait to dive deep into all things #regenerativeag, #climate, #impactinvesting over the next couple of days with friends old and new at the Regenerative Food Systems Investment Forum. This should be a very interesting experience relative to #climateweeknyc a couple weeks ago, and I'm excited to see what carries over and what is distinct. I know we'll be closer to action on the ground here, which I find particularly inspiring on a personal level, but the sheer scale of efforts evident at Climate Week is inspiring in it's own way as well. Related: I am truly honored to be named on the "40 Under 40" list by the St. Louis Business Journal, but I have to admit that being in the "just barely still under 40" camp, I'm more focused than ever on how we turn all the talent, technology, energy, and investment in our space into real impact at scale. At HabiTerre, we are tirelessly working to bridge the gap between rigor and scale to develop environmental markets in agriculture. True, meaningful impact requires both scientific integrity in how we measure/incentivize outcomes and the ability to bring that to scaled application. One thing I know for certain: uncertainty does not justify inaction. We'll all have to be a little brave in the process knowing that there is no such thing as a perfectly right climate solution, but there is a perfectly wrong one: doing nothing while waiting for a perfect solution.

There's still time to sign up for this event, co-hosted by @AHNSEndo & @ThyCaInc where we'll discuss recurrences. Join us: https://lnkd.in/g9Z-iqCh #ThyroidCancer #ThyCa #ThyroidCancerSurvivor #ThyCaSurvivor #ThyroidCancerWarrior #ThyCaWarrior

The fallacy of sepsis diagnosis is that a single test/biomarker can solve for the answer. Since sepsis is a complex syndrome and not a diagnosis in the traditional sense Novel and unconventional approaches are required for its early and accurate detection. Check out sepsis Immunoscore.